AstraZeneca Withdraws Andexxa, Unable To Find Path Forward With US FDA

 
• By Sue Sutter
  
Two directions
The FDA and AstraZeneca could not agree on a path to convert Andexxa to regular approval. (Shutterstock)

More from Review Pathways

More from United States